News
Ferrer joins Barcelona + B, a project to bring the business community closer to the SDGs
News
First patient enrolled in Ferrer's FNP122 ADORE Phase III clinical trial for Amyotrophic Lateral Sclerosis (ALS) treatment
Our activities
This allows us to commit to initiatives that make a positive impact in society
Would you like to ask us a question? Contact us.
For queries, to request medical information, become a partner, request an interview, report an adverse reaction or lodge a quality complaint, please leave us a message.
Link